Clinical Trial Update: A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults [Phase 4]

View source ↗

Summary

Phase 4 bioequivalence trial comparing Idiazole 20 mg DR tablets to PARIET 20 mg DR tablets after a single oral dose in healthy adults under fasting conditions.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Diseases

Drugs mentioned

• Idiazole 20mg DR Tabs (Idiazole)
• PARIET 20 mg DR Tabs (rabeprazole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Gastrointestinal Diseases | Phase 4 | Status: COMPLETED | Results posted: 2017-06-14